Citation: Frl. Crijns et al., STREPTOZOTOCIN-INDUCED DIABETICS IN DAHL SALT-SENSITIVE RATS A MODEL THAT COMBINES DIABETES AND HYPERTENSION, Hypertension, 32(4), 1998, pp. 1-1
Authors:
WOLFFENBUTTEL BHR
BOULANGER CM
CRIJNS FRL
HUIJBERTS MSP
POITEVIN P
SWENNEN GNM
VASAN S
EGAN JJ
ULRICH P
CERAMI A
LEVY BI
Citation: Bhr. Wolffenbuttel et al., BREAKERS OF ADVANCED GLYCATION END-PRODUCTS RESTORE LARGE ARTERY PROPERTIES IN EXPERIMENTAL DIABETES, Proceedings of the National Academy of Sciences of the United Statesof America, 95(8), 1998, pp. 4630-4634
Citation: Frl. Crijns et al., STREPTOZOTOCIN-INDUCED DIABETES IN DAHL SALT-SENSITIVE RATS - A MODELTHAT COMBINES DIABETES AND HYPERTENSION, Diabetologia, 41, 1998, pp. 1318-1318
Authors:
WOLFFENBUTTEL BHR
BOULANGER CM
CRIJNS FRL
POITEVIN P
EGAN JJ
CERAMI A
LEVY BI
Citation: Bhr. Wolffenbuttel et al., ALT-711, A BREAKER OF ADVANCED GLYCATION ENDPRODUCTS (AGES), RESTORESLARGE ARTERY ELASTICITY IN EXPERIMENTAL DIABETES, Diabetes, 47, 1998, pp. 88-88
Citation: Frl. Crijns et al., CYCLIC-GMP PRODUCTION IN CAROTID ARTERIES OF DIABETIC RATS - CHRONIC EFFECTS OF AMINOGUANIDINE, Diabetologia, 39, 1996, pp. 1093-1093
Authors:
CRIJNS FRL
WOLFFENBUTTEL BHR
VANESSEN H
BOUDIER HAJS
Citation: Frl. Crijns et al., ACE-INHIBITOR TREATMENT DOES NOT REVERSE MESENTERIC-ARTERY CHANGES INEXPERIMENTAL DIABETES, Diabetologia, 38, 1995, pp. 221-221
Citation: Bhr. Wolffenbuttel et al., CHRONIC AMINOGUANIDINE TREATMENT CAUSES HYPERRESPONSIVENESS TO VASOPRESSOR AGENTS IN RATS, Diabetologia, 38, 1995, pp. 262-262
Citation: Msp. Huijberts et al., AMINOGUANIDINE REDUCES REGIONAL ALBUMIN CLEARANCE BUT NOT URINARY ALBUMIN EXCRETION IN STREPTOZOTOCIN-DIABETIC RATS, Diabetologia, 37(1), 1994, pp. 10-14
Authors:
HUIJBERTS MSP
WOLFFENBUTTEL BHR
BOUDIER HAJS
CRIJNS FRL
KRUSEMAN ACN
POITEVIN P
LEVY BI
Citation: Msp. Huijberts et al., AMINOGUANIDINE TREATMENT INCREASES ELASTICITY AND DECREASES FLUID FILTRATION OF LARGE ARTERIES FROM DIABETIC RATS, The Journal of clinical investigation, 92(3), 1993, pp. 1407-1411